Cornea/External Disease News

Patients with ocular monkeypox experienced delays in treatment, prolonged illness, hospitalization and, in one case, significant vision impairment, according to a CDC report.

Look what my Secret Santa brought me!

The Meivertor, a new device designed to evert the upper eyelid for improved imaging of meibomian glands, was introduced at Academy 2022 in San Diego.

Patients consistently rated Biotrue Hydration Plus above 85 on a scale of 0 to 100 when assessing performance, comfort, vision, impression and cleanliness with their current contact lenses, according to a study presented at Academy 2022.

NEW YORK — Small-aperture IOLs are an important tool for managing patients with challenging eyes, according to an expert at OSN New York.

The Vision Council has released findings from its Focused inSights 2022: Digital Habits survey, which highlight recent developments in telehealth and increased technology use in optometry, according to a council press release.

Okyo Pharma has submitted an investigational new drug application to the FDA for OK-101 for the treatment of dry eye disease.

AZR-MD-001 ophthalmic ointment showed positive 3-month safety and efficacy results for the treatment of meibomian gland dysfunction, according to a press release from Azura Ophthalmics.

SAN DIEGO — Alcon announced plans to introduce a toric design for its Total30 contact lenses in early 2023, according to company executives who spoke during a press conference for the company’s 75th anniversary at Academy 2022.

NEW YORK — In this Healio Video Perspective from OSN New York, John A. Hovanesian, MD, FACS, discusses the IC-8 Apthera IOL from AcuFocus, designed to correct up to 1.5 D of astigmatism.